Ebara S - Search Results

1

Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer.

Ebara S, Katayama N, Tanimoto R, Edamura K, Nose H, Manabe D, Kobayashi T, Kobayashi Y, Kobuke M, Takemoto M, Saika T, Nasu Y, Kanazawa S, Kumon H. Ebara S, et al. Acta Med Okayama. 2008 Feb;62(1):9-13. Acta Med Okayama. 2008. PMID: 18323866 Free article. Clinical Trial.

2

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.

Satoh T, Timme TL, Saika T, Ebara S, Yang G, Wang J, Ren C, Kusaka N, Mouraviev V, Thompson TC. Satoh T, et al. Among authors: ebara s. Hum Gene Ther. 2003 Jan 20;14(2):91-101. doi: 10.1089/104303403321070793. Hum Gene Ther. 2003. PMID: 12614561

3

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.

Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC. Ebara S, et al. Prostate Cancer Prostatic Dis. 2002;5(4):316-25. doi: 10.1038/sj.pcan.4500610. Prostate Cancer Prostatic Dis. 2002. PMID: 12627218

4

[Suicide gene therapy for prostate cancer--update of current development].

Ebara S, Nasu Y. Ebara S, et al. Nihon Rinsho. 2003 Jul;61(7):1257-65. Nihon Rinsho. 2003. PMID: 12877094 Review. Japanese.

5

Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.

Satoh T, Saika T, Ebara S, Kusaka N, Timme TL, Yang G, Wang J, Mouraviev V, Cao G, Fattah el MA, Thompson TC. Satoh T, et al. Among authors: ebara s. Cancer Res. 2003 Nov 15;63(22):7853-60. Cancer Res. 2003. PMID: 14633713

6

Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma.

Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R, Arao Y, Miyazaki M, Tsushima T, Namba M, Kumon H, Huh NH. Kurose K, et al. Among authors: ebara s. J Urol. 2004 Mar;171(3):1314-8. doi: 10.1097/01.ju.0000101047.64379.d4. J Urol. 2004. PMID: 14767340

7

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.

Saika T, Satoh T, Kusaka N, Ebara S, Mouraviev VB, Timme TL, Thompson TC. Saika T, et al. Among authors: ebara s. Cancer Gene Ther. 2004 May;11(5):317-24. doi: 10.1038/sj.cgt.7700709. Cancer Gene Ther. 2004. PMID: 15044961

8

[Adenovirus-mediated interleukin-12 gene therapy for prostate cancer].

Nasu Y, Ebara S, Kumon H. Nasu Y, et al. Among authors: ebara s. Nihon Rinsho. 2004 Jun;62(6):1181-91. Nihon Rinsho. 2004. PMID: 15206161 Review. Japanese.

9

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer.

Miyaji Y, Saika T, Yamamoto Y, Kusaka N, Arata R, Ebara S, Nasu Y, Tsushima T, Kumon H. Miyaji Y, et al. Among authors: ebara s. Urology. 2004 Jul;64(1):128-31. doi: 10.1016/j.urology.2004.03.012. Urology. 2004. PMID: 15245949

10

Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.

Kaku H, Ito S, Ebara S, Ouchida M, Nasu Y, Tsushima T, Kumon H, Shimizu K. Kaku H, et al. Among authors: ebara s. Urology. 2004 Jul;64(1):176-81. doi: 10.1016/j.urology.2004.03.015. Urology. 2004. PMID: 15245966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters